# Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

> **NCT02765373** · — · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Exemestane
- **DRUG:** Letrozole
- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT02765373
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-01
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02765373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02765373, "Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02765373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*